Summary
I graduated from Athens Medical School in 1983 and completed internal medicine training in 1990. In 1995 I was awarded my PhD from the University of London on monoclonal antibodies in Head and Neck Cancer. I completed my cancer specialty training as a lecturer at St George's hospital studying the immunology of melanoma cell vaccine therapeutics. I was appointed as a Senior Lecturer at the University of Hull in 1999 part of the founding team of Hull York Medical School, where I became professor of Cancer Medicine in 2012.
I am also a honorary consultant in the Hull University Teaching Hospitals NHS Trust (HUTH) having also been the Director of R&D till 2021. I treat and am involved in clinical trials in pancreaticobiliary, kidney cancer and melanoma and have particular clinical and basic science research interest in cancer associated thrombosis (CAT).
I have been national and international chief investigator for a number of studies in CAT and have worked on international guideline bodies for this condition. I have published widely in CAT with particular focus on the thromboprophylaxis of the ambulatory cancer patient and the management of incidental pulmonary embolism in cancer patients.
Journal Article
Calcitonin gene-related peptide and intermedin induce phosphorylation of p44/42 MAPK in primary human lymphatic endothelial cells in vitro
Hasan, S. R., Manolis, D., Stephenson, E., Ryskiewicz-Sokalska, O. A., Maraveyas, A., & Nikitenko, L. L. (2024). Calcitonin gene-related peptide and intermedin induce phosphorylation of p44/42 MAPK in primary human lymphatic endothelial cells in vitro. Cellular Signalling, 121, Article 111261. https://doi.org/10.1016/j.cellsig.2024.111261
Quantitative proteomics reveals CLR interactome in primary human cells
Manolis, D., Hasan, S., Maraveyas, A., O'Brien, D. P., Kessler, B. M., Kramer, H., & Nikitenko, L. L. (2024). Quantitative proteomics reveals CLR interactome in primary human cells. Journal of Biological Chemistry, 300(6), Article 107399. https://doi.org/10.1016/j.jbc.2024.107399
Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series
Brown, M., O’Connor, D., Turkington, R., Eatock, M., Vince, R., Hulme, C., Bowdery, R., Robinson, R., Wadsley, J., Maraveyas, A., & Prue, G. (2023). Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series. BMC Sports Science, Medicine and Rehabilitation, 15(1), Article 116. https://doi.org/10.1186/s13102-023-00722-3
Presentation / Conference Contribution
Abstract B001: Calcitonin receptor-like receptor agonists induce p44/42 MAPK phosphorylation in VEGF-A-stimulated human blood endothelial cells after bevacizumab treatment
Morfitt, M. A., Greenman, J., Maraveyas, A., & Nikitenko, L. L. Abstract B001: Calcitonin receptor-like receptor agonists induce p44/42 MAPK phosphorylation in VEGF-A-stimulated human blood endothelial cells after bevacizumab treatment. Presented at AACR Special Conference: Advances in Kidney Cancer Research, Austin, Texas, U.S.A